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Hee Yoon Ahn1, So Young Hong1, Ji Yeon Kim2 and Oran Kwon1*Abstract
The root of Panax ginseng C.A. Meyer has been shown to induce nitric oxide (NO) release resulting in a hypotensive
effect. However, the main active component contributing to vascular endothelium relaxation remains uncertain. In
this study, we hypothesized that multiple components of ginseng extract might have combinatory effects
providing greater health benefits than a single ginsenosides. To test this hypothesis, we compared the NO-releasing
and endothelial NO synthase (eNOS) activating potency of wide range of ginseng extracts (crude extract, CE;
protopanaxatriol-enriched extract, TE; protopanaxadiol-enriched extract, DE) and individual ginsenosides (Rg1, Re
and Rb1) in human umbilical vein endothelial cells. We found that TE had the highest potency in NO production,
followed by CE, DE, and Rg1. We also observed that TE-treatment resulted in rapid activation of intracellular
signaling pathways, immediate linear rise of NO, and increased eNOS activation. TE-induced activation of eNOS was
abolished by pretreatment with wortmannin (inhibitor for PI3K-Akt), compound C (inhibitor for AMP activated
protein kinase, AMPK) or L-NAME (inhibitor for NOS), whereas Rg1-induced eNOS phosphorylation was only partially
attenuated. Further analysis revealed that TE, but not Rg1, results in AMPK phosphorylation at Thr172. These novel
finding add evidence that the multiple components of Panax ginseng extract rich in protopanaxatriol offers
combinatorial effects in NO production and vascular endothelium relaxation via multiple signaling pathways.
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Ginseng, the root of Panax ginseng C.A. Meyer, has been
widely used as both a medicine and a food in Asia for
thousands of years (Helms 2004). Recently, there has
been a renewed interest in investigating the health bene-
fits of ginseng as well as its constituents by using mod-
ern techniques. Numerous studies have reported that
ginseng functions as a free radical scavenger (Kang et al.
2006; Kitts and Hu 2000) and an immunomodulator
(Lee et al. 2005), contributing towards maintaining opti-
mal health against certain chronic disease states and
aging (Kitts and Hu 2000). More specifically, it has been
demonstrated that ginseng had a potency to reduce* Correspondence: orank@ewha.ac.kr
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in any medium, provided the original work is pblood pressure by regulating vascular tone through in-
duction of nitric oxide (NO) release in endothelial cells
(Gillis 1997). Production of NO has been known to be
induced by calcium-dependent endothelial nitric oxide
synthase (eNOS), whose activity is regulated under vari-
ous circumstances (Hien et al. 2010; Edirisinghe et al.
2008).
To date, more than hundred of ginsenosides has been
identified from Araliaceae family (Jia and Zhao 2009a,
Jia et al. 2009b) and are classified into two categories
based on the presence or absence of a carboxyl group at
the C-6 position; protopanaxadiols (PPDs) (e.g. Rb1,
Rb2, Rc, Rd ,Rg3 and Rh2) and protopanaxatriols (PPTs)
(e.g. Re, Rf, Rg1, Rg2 and Rh1), respectively (Gillis,
1997). Typically, researchers have elucidated the mech-
anism of action of ginseng by treating human endothelial
cells with highly purified individual ginsenosides. LeungOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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as functional ligands for the glucocorticoid receptor,
leading to rapid NO production. Yu et al. (Yu et al.
2007) reported that Rb1 induces NO production via an-
drogen receptor-mediated eNOS phosphorylation. Hien
et al. (Hien et al. 2010) investigated effects of Rg3 on
endothelial NO production. Despite this large array of
data for individual ginsenosides, the main active ginseng
component contributing to vascular endothelium relax-
ation still remains uncertain.
In addition, since different ginsenosides produce dif-
fering effects, it has long been assumed that multiple
components in ginseng extract can provide greater
health benefits than a single ginsenoside (Kim and Kwon
2011; Low 2006). However, the combinatorial effect of
multiple ginseng components in ginseng extract on NO
production has not been well studied. Therefore, we
investigated the study to compare ginseng extracts and
individual ginsenosides for inducing NO production in
human endothelial cells. To test this aim, a wide range
of samples were prepared, including crude extract (CE),
PPT-enriched extract (TE), PPD-enriched extract (DE)
and single ginsenosides. Furthermore, to provide mech-
anistic explanations, we also compared the impacts of a
selected extract and an equivalent amount of single
ginsenoside (TE vs Rg1) on the activation of signaling
pathways by using inhibitors.
Results and discussion
Comparison of NO producing ability
In our previous study, we demonstrated that administra-
tion of TE stimulated eNOS activation, enhanced NO
production, improved vessel wall thickening, and allevi-
ated hypertension in spontaneously hypertensive rats
(Hong et al. 2012). In this study, as part of our continu-
ous effort to test whether the presence of multiple active
ginseng components may exert combinatorial effects, we
compared the NO producing ability of a wide range of
samples (Figure 1).Panax ginseng C.A. Meyer
Crude extract (CE)





PPT-enriched extract (TE) PPD-enriched extract (DE)
Concentration
Figure 1 Schematic flow diagram of the ginseng
extract preparation.First, comparison of the intracellular bio-imaging of
NO was performed by using 4,5-diaminofluorescein
diacetate (DAF-2DA). Human umbilical vein endothelial
cells (HUVECs) were treated with each sample (150 μg/
mL of CE, TE, or DE contains 25.8 μM of Rg1, 31.1 μM
of Re or 52 μM of Rb1, respectively.) for 10 min, fixed,
and then viewed by a fluorescence microscope. Sample
concentrations were determined based on our previous
in vivo study (Hong et al. 2012) and bioavailability of
ginsenosides (Feng et al. 2010); Rg1 and Re concentra-
tions were equivalent to those found in TE and Rb1 con-
centration was equivalent to those found in DE.
Membrane permeable DAF-2 DA is taken-up by the
cells and hydrolyzed by cellular esterase to form the
membrane-impermeable compound 4,5-diaminofluo-
rescein (DAF-2). As shown in Figure 2A, we observed a
marked increase in intracellular DAF-2 in cells treated
with TE. An increase was observed in cells treated with
CE, DE and Rg1. However, little DAF-2 production was
detected in cells treated with Re or Rb1.
Broillet et al. (Broillet et al. 2001) questioned whether
real-time biological detection of NO concentration is
really directly correlated with NO release. Therefore, to
confirm our results, we measured extracellular NO re-
lease from HUVECs. Consistent with increased NO pro-
duction in the cell, we detected a significant increase in
DAF-2 fluorescence intensity in the extracellular media
in response to TE > CE > DE > Rg1 compared to the con-
trol (Figure 2B). In contrast, Re and Rb1 treatment had
no significant effect on NO release from the endothelial
cells. These results support our hypothesis that multiple
components in ginseng extract are more potent in indu-
cing NO production than single ginsenosides, implicat-
ing the combinatorial interactions of these compounds.
However, it should be noted that TE showed greater
potency than CE and DE. This might be attributed to
the lower concentration of each active ginsenoside in CE
or the differential effects of PPTs on the production of
NO. For individual ginsenosides, Kang et al. (Kang et al.
1995) reported that Rg1 or Re treatment induced
endothelium-dependent relaxation in rat aortas, whereas
Rb1 or Rc treatment did not.
Ginsenosides are amphipathic in nature. Thus, they
can directly interact with specific membrane proteins,
triggering intracellular responses (Yue et al. 2007) and/
or can traverse cell membranes and bind nuclear recep-
tors primarily affecting mRNA transcription and, subse-
quently, protein synthesis (Attele et al. 1999). While
transcriptional effects with subsequent modification of
protein expression requires hours to days to occur (Russell
et al. 2000), we found that TE exposure at 150 μg/
mL concentration led to an linear increase in NO pro-
duction and a plateau after 5 min (Figure 3), suggesting
TE -induced NO production is mediated by rapid
Control CE TE DE
Rg1 Re Rb1

























Figure 2 Effect of ginseng extracts and individual ginsenosides on NO production in HUVECs. Confluent cells were incubated with
150 μg/mL ginseng extracts (CE, TE and DE), 26 μM Rg1, 31 μM Re, or 52 μM Rb1 for 10 min. Bio-imaging of intracellular NO (A) and NO release
(B) were measured using DAF-2 DA and DAF-2, respectively. Each bar represents mean ± SD from three separate wells per condition. * P < 0.05
compared with control.
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stressed that HUVECs (Figure 3A) and the immortalized
EA.hy926 cell line (Figure 3B) showed similar patterns in
NO production in response to treatment, but basal NO
production is higher in EA.hy926 cells compared to pri-
mary HUVECs. Thus, EA.hy926 cells were used for the
subsequent experiments.
Comparison of PI3K/Akt-mediated eNOS phosphorylation
What intracellular signaling pathways are required for
the TE-induced increase in NO production in endothe-
lial cells? Accumulating evidence indicates that a num-
ber of protein kinases induce activation of eNOS by
phosphorylating Ser1177 or Thr495 in endothelial cells.
Based on previous studies (Chen et al. 1999), we focused
on Akt- and AMP activated protein kinase (AMPK)-Incubation time (min)
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Figure 3 Time-course of TE-induced NO release in HUVECs (A) and EA
(● control) and time-dependent NO release was quantified at 0, 1, 3, 5, 15
three separate wells per condition.mediated phosphorylation of eNOS at Ser1177. TE and
the equivalent amount of Rg1 were used for all subse-
quent experiments in the absence or presence of
wortmannin (inhibitor of Akt signaling, 10 μM), com-
pound C (inhibitor of AMPK signaling, 10 μM), or NG-
nitro-L-arginine methyl ester (L-NAME) (inhibitor of
NO synthase, 100 μM) in EA.hy926 cells.
Consistent with increased NO release, eNOS phosphor-
ylation was observed in cells treated with 150 μg/mL TE
or 25.8 μM Rg1 for 10 min, and this effect was more pro-
nounced in TE-treated cells (p = 0.01) than in Rg1-treated
cells (p = 0.08), as shown in Figure 4. It also showed that
TE-induced eNOS phosphorylation was abolished by pre-
treatment with inhibitors for PI3K/Akt, AMPK or NO
synthase (Figure 4A). In contrast, pretreatment of these
inhibitors only partially attenuated Rg1-induced eNOSIncubation time (min)


















.hy926 (B) cells. Cells were exposed to TE (○) or 1% DMSO



















































Figure 4 Inhibition of TE- or Rg1-induced eNOS activation in EA.hy926 cells. Confluent EA.hy926 cells were pretreated with wortmannin
(PI3K/Akt inhibitor, 10 μM), compound C (AMPK inhibitor, 10 μM), or L-NAME (NOS inhibitor, 100 μM) for 30 min, then treated with 150 μg/mL TE
(A) or 26 μM Rg1 (B) for 10 min. Representative western blots of intracellular eNOS or ß–actin are presented. Quantitative analysis of optical
density of eNOS (normalized to the density of ß–actin) is shown at the bottom. Each bar represents mean ± SD, from three separate wells per
condition. *P < 0.05 compared with control. #P < 0.05 compared with TE stimulation without inhibitor.
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data is that the stronger signals induced by TE treatment
is attributed to the activation of multiple signaling path-
ways (Attele et al. 1999). Consistent with our results, sev-
eral lines of evidence have demonstrated that Rg1 plays a
role in PI3K/Akt-mediated eNOS phosphorylation leading
to NO production in endothelial cells (Leung et al. 2006).
In our previous work, we also demonstrated that TE acti-
vated eNOS phosphorylation via the activation of Akt in
rats (Hong et al. 2012).
Comparison of AMPK-mediated eNOS phosphorylation
However, there is lack of information concerning the role
of ginsenosides in relation to AMPK-mediated phosphor-
ylation of eNOS. To dissect the signaling pathway re-
quired for phosphorylation of AMPK at Thr172 and
subsequent phosphorylation of eNOS, we treated EA.
hy926 cells with TE or Rg1 in the presence or absence of
various inhibitors. Figure 5 showed that phosphorylation
of AMPK markedly decreased below control level by pre-
treatment with compound C in both TE-treated (p = 0.02)
and Rg1-treated (p = 0.08) cells, demonstrating noticeable
inhibition of constitutive activation of AMPK. Interest-
ingly, the result also revealed that there was a tendency to
increase the phosphorylation of AMPK by TE treatment
(p = 0.17) (Figure 5A), whereas Rg1 treatment did not
affect AMPK activation (Figure 5B). As for the effect of
ginsenosides on the phosphorylation of AMPK, recently,Hien et al. (2010) demonstrated AMPK-dependent eNOS
phosphorylation in Rg3-treated endothelial cells. They
also showed that Rg3-stimulated eNOS phosphorylation
was reversed by AMPK inhibition. However, no report
was found in the literature regarding the effect of Rg1 on
AMPK-mediated eNOS phosphorylation.
Conclusions
Our results clearly demonstrate that TE, a PPT-enriched
ginseng extract, is superior in inducing NO production,
compared to CE, DE, or individual ginsenosides in hu-
man endothelial cells. The stronger ability of TE to in-
duce NO production is likely attributed to activation of
multiple signal pathways, including Akt- and AMPK-
mediated phosphorylation of eNOS. The novel findings
of this study provide additional evidence that the diverse
array of PPTs in TE likely provides better health benefits
via combinatorial interactions to stimulate multiple sig-
naling pathways. Importantly, the present study was
conducted with the consideration of ginsenosides only,
given that the NO production potency of ginseng are at-
tributed to ginsenosides; therefore the results reported
here may provide limited insight on the potency of non-
ginsenoside constituents of ginseng. However, the
present study may serve as a strategy to find the most
appropriate preparation for plant extracts to achieve the


























































Figure 5 Inhibition of TE- or Rg1-induced AMPK activation in EA.hy926 cells. Confluent EA.hy926 cells were pretreated with wortmannin
(PI3K/Akt inhibitor, 10 μM), compound C (AMPK inhibitor, 10 μM), or L-NAME (NOS inhibitor, 100 μM) for 30 min, then treated with 150 μg/mL TE
(A) or 26 μM Rg1 (B) for 10 min. Representative western blots of intracellular AMPK or ß–actin are presented. Quantitative analysis of optical
density of AMPK (normalized to the density of ß–actin) is shown at the bottom. Each bar represents mean ± SD, from three separate wells per
condition. #P < 0.05 compared with TE stimulation without inhibitor.
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Reagents
Ginsenoside Re, Rb2, Rc, Rd, Rg1 and Rb1 were pur-
chased from ChromaDex (Irvine, CA, USA). L-NAME
(NO synthase inhibitor) and compound C (AMPK in-
hibitor) were purchased from Cayman Chemical (Ann
Arbor, MI, USA). Wortmannin (PI3K-Akt inhibitor) was
purchased from Sigma (St. Louis, MO, USA). Antibodies
(eNOS, phospho-eNOSSer 1177; AMPK, and AMPKThr172)
were purchased from Cell Signaling Technology (Beverly,
MA, USA). HUVECs, the immortalized HUVEC cell
line EA.hy 926 and culture medium were purchased
from the American Type Culture Collection (Bethesda,
MD, USA). DAF-2 and DAF-2 DA were purchased from
Alexis Biochemicals (Grünberg, Germany) and Cayman
Chemical, respectively.Table 1 Content of major ginsenosides in test materials
Preparations Protopanaxatriol type
Rg1 (mg/g) Re (mg/g)
Crude extract (CE) 5.9 18.2
PPT-enriched extract (TE) 136.7 325.6
PPD-enriched extract (DE) 14.1 26.9Preparation of ginseng extracts
The CE, TE and DE were kindly provided by CJ
Cheiljedang Corp. (Seoul, Korea). Briefly, dried ginseng
(Panax ginseng C.A. Meyer) roots were cut into small
pieces and refluxed in 70% ethanol. After removing etha-
nol, CEs were eluted on DIAION HP-20 ion exchange
resin (Mitsubishi Chemical Co., Tokyo, Japan) to obtain
TE and DE by 40% ethanol elution and by both 100%
and 80% ethanol elution, respectively (Figure 1). The
yields were found to be 50%, 1% and 5% for CE, TE and
DE, respectively. The major ginsenosides in freeze-dried
extracts were quantified by comparison with standards
using an Agilent 1100 HPLC system (Palo Alto, CA,
USA) equipped with a reversed-phase column (Venusil
XBP C18, 250 X 4.6 mm, i.d. 5 μm, Agela Technology,
Newark, DE, USA) (Table 1).Protopanaxadiol type
Rb1 (mg/g) Rb2 (mg/g) Rc (mg/g) Rd (mg/g)
25 13.5 27.3 9.6
63.1 29.2 73.2 11.5
229.9 132.2 261.2 81.3
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For NO production assay, confluent cells in 12-well
plates were serum-starved overnight and treated with
the respective samples in Ca+2-containing phosphate
buffered saline for 10 min at 37°C. For inhibitor assays,
confluent cells in 100 mm dishes were serum-starved
overnight, pretreated with different inhibitors (L-NAME,
100 μM; wortmannin, 10 μM; compound C, 10 μM) for
30 min, and then treated with TE or Rg1 for 10 min.
Ginseng extracts and ginsenosides were prepared fresh
by diluting a 100-fold concentrated stock solution pre-
pared in dimethyl sulfoxide.
Measurement of intracellular and extracellular NO
production
For intracellular NO production, confluent cells were
pre-incubated with 5 μM DAF-2 DA for 30 min at 37°C
in darkness, rinsed with fresh suspension buffer to re-
move excess fluorophore, and treated with the respective
samples for 10 min. The cells were fixed in 2% parafor-
maldehyde and green fluorescence zimages obtained
using a fluorescent microscope (Nikon ECLIPSE TS 100,
Nikon, Tokyo, Japan) at 495 nm excitation and 515 nm
emission wavelength (Kojima et al. 1998). For extracellu-
lar NO release, DAF-2 (1 μM) was added in assay
medium for 5 min at 37°C in darkness after treatment
with respective samples. Aliquots of the solutions were
sampled and fluorescence was measured using a Thermo
Scientific Fluorometer (Barrington, IL, USA) at 495 nm
excitation and 515 nm emission wavelength (Leikert
et al. 2001).
Western blot analysis
Cells were stimulated with respective samples for 10 min
and then lysed in lysis buffer. Equal quantities of protein
were resolved by SDS-polyacrylamide gel electrophoresis
and transferred onto polyvinylidene difluoride membranes
(Bio-Rad, Hercules, CA, USA). The proteins were probed
with the indicated primary antibodies, and then incubated
either goat anti-rabbit or goat anti-mouse secondary anti-
body. Bands were visualized using the West-one Western
Blot Detection System (iNtRON Biotechnology, Korea).
Band intensity was quantified using ChemiDoc XRS +
Systems with Image Lab software (Bio-Rad, Hercules, CA,
USA) and normalized to β-actin (Santa Cruz Biotechnol-
ogy) densitometric values.
Statistical analysis
All data shown are representative of at least three exper-
iments that yielded similar results. Data are presented as
the mean of triplicate samples with error bars indicative
of the standard deviations. The numerical results were
analyzed using one-way analysis of variance with post
hoc Dunnett’s multiple range tests. P <0.05 wasconsidered statistically significant. Statistical analyses
were performed using the SAS package version 9.2 (SAS
Institute, Cary, NY).
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